TALLAHASSEE — A raucous and rowdy debate unfolded late Friday afternoon at a state public hearing to consider a contentious DeSantis administration proposal that would deny Medicaid insurance coverage for treatments that include puberty-blocking medication and hormone therapy for Florida’s low-income transgender individuals.

The hearing in Tallahassee before the Florida Agency for Health Care Administration, or AHCA, focused on gender dysphoria, which the federal government defines as clinically “significant distress that a person may feel when sex or gender assigned at birth is not the same as their identity.” It was previously called “gender identity disorder.”

No final decision was rendered Friday, but more than 70 public speakers registered to speak, expressing a variety of religious, political and medical views to the panel, with more supporters for the DeSantis administration proposal than critics amid the standing-room only crowd.